GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stereotaxis Inc (FRA:RJR1) » Definitions » 1-Year ROIIC %

Stereotaxis (FRA:RJR1) 1-Year ROIIC % : -8.36% (As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Stereotaxis 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Stereotaxis's 1-Year ROIIC % for the quarter that ended in Sep. 2024 was -8.36%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Stereotaxis's 1-Year ROIIC % or its related term are showing as below:

FRA:RJR1's 1-Year ROIIC % is ranked worse than
59.66% of 833 companies
in the Medical Devices & Instruments industry
Industry Median: 1.87 vs FRA:RJR1: -8.36

Stereotaxis 1-Year ROIIC % Historical Data

The historical data trend for Stereotaxis's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stereotaxis 1-Year ROIIC % Chart

Stereotaxis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -41.35 313.46 -132.80 -177.94 123.61

Stereotaxis Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 160.79 123.61 19.64 25.16 -8.36

Competitive Comparison of Stereotaxis's 1-Year ROIIC %

For the Medical Instruments & Supplies subindustry, Stereotaxis's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stereotaxis's 1-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stereotaxis's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Stereotaxis's 1-Year ROIIC % falls into.



Stereotaxis 1-Year ROIIC % Calculation

Stereotaxis's 1-Year ROIIC % for the quarter that ended in Sep. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -20.541 (Sep. 2024) - -19.609 (Sep. 2023) )/( 30.733 (Sep. 2024) - 15.995 (Sep. 2023) )
=-0.932/14.738
=-6.32%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Stereotaxis  (FRA:RJR1) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Stereotaxis 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Stereotaxis's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Stereotaxis Business Description

Traded in Other Exchanges
Address
710 North Tucker Boulevard, Suite 110, St. Louis, MO, USA, 63101
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.

Stereotaxis Headlines

No Headlines